A Study of LY3484356 in Women With Breast Cancer Before Having Surgery
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: LY3484356
Sponsor: Eli Lilly and Company